DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab
Clinical trial NCT04954339 · COMPLETED
Trial details
- NCT number
- NCT04954339
- Sponsor
- Tae Won Kim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-29
- Primary completion
- 2025-10-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.